Latest news with #Rushdan
The Star
6 days ago
- Business
- The Star
New products from CGS International
KUALA LUMPUR: CGS International Securities Pte Ltd (CGS International), through its subsidiary CGS International Securities Malaysia Sdn Bhd has unveiled its latest Islamic structured investment product offerings namely the Islamic Equity Linked Investment Notes (ELIN-i) and Islamic Autocallable Equity Structured Investment Notes (AESIN-i). Group head of syariah services Rushdan Nadzir said the offerings represented a major milestone as they are the first syariah-compliant equity-linked structured investment products in Malaysia, tailored for affluent and institutional investors. 'These products reflect not only our commitment to innovation but also shared mission to support the country's position as a global leader in Islamic finance,' he said at the launch of the products. He highlighted that the vision for the products is consistent with Bank Negara's Financial Sector Blueprint 2022 to 2026, which aims to strengthen Malaysia's role as a leading Asean financial hub. Rushdan also said Malaysia's Islamic capital market is valued at over RM2.6 trillion, making up 63% of the country's total capital market. ELIN-i and AESIN-i leverage Malaysia's rich legacy as a leader in global Islamic finance and CGS's proven investment capabilities to offer sophisticated investors alternatives to capitalise on broader opportunity in equities and syariah, but in a structured manner.' ELIN-i and AESIN-i offer structured exposure designed for high net-worth individuals and high net-worth entities. —Bernama
New Straits Times
6 days ago
- Business
- New Straits Times
CGS eyes regional growth in Islamic finance, eyes MENA expansion
KUALA LUMPUR: CGS International Securities Malaysia Sdn Bhd (CGS MY) is broadening its Islamic finance presence across the region, targeting markets such as Singapore, Indonesia, and eventually the Middle East and North Africa (MENA), with Dubai in its sights. According to head of Shariah services Rushdan Nadzir, navigating regulatory hurdles remains a challenge due to differing interpretations of Islamic finance, particularly in jurisdictions like Saudi Arabia and Indonesia, where structures like Tawarruq face tighter scrutiny. Nonetheless, CGS MY is pushing ahead with its expansion plans, with a strong focus on accelerating its Islamic finance growth in Indonesia. "We see from the movements during the pandemic and post-pandemic as well, and I guess the overall awareness around these Shariah products is needed. We want to provide access to ethical, high-yield investments that are scalable and rooted in compliance. Whether you are investing RM10 or RM100,000, there should be no trade-off between faith, function, and return," said Rushdan. CGS MY recently launched its first Islamic structured investment products—the Islamic equity-linked investment notes (Elin-i) and Islamic autocallable equity structured investment notes (Aesin-i)—designed for high-net-worth and institutional investors. Rushdan said the launch marked a strategic milestone in positioning Malaysia as a regional hub for Islamic financial innovation. "These structured products are a high-risk, high-return investment, with indicative returns ranging from potentially 8 to 15 per cent per annum. "As outlined in Bank Negara Malaysia's Financial Sector Blueprint 2022 to 2026, the launch supports CGS's position as a leading Islamic finance hub in Asean," he said, adding that these high-risk, high-return products offer potential annual returns of 8–15 per cent. Rushdan said that Malaysia's Islamic capital market is now valued at over RM2.6 trillion, accounting for 63 per cent of the total capital market, while the country also holds 36 per cent of the global sukuk market share as of end-2024. The firm noted that Shariah-compliant stocks have historically outperformed, particularly in Malaysia. "Although Shariah-compliant assets currently account for roughly 20 per cent of CGS MY's business, the segment is expanding rapidly. "CGS's Islamic share margin financing grew from zero to over RM100 million in just two years, and demand is also growing in futures, equity trading, and Islamic wealth management," he said. According to him, institutional clients, particularly fund managers with Islamic mandates, are increasingly conducting trades through Shariah-compliant brokers.
The Star
19-05-2025
- Health
- The Star
QuickCheck: Does a conspiracy theory link Covid-19 vaccine to HIV?
IN THE digital age, misinformation spreads swiftly, often blurring the lines between fact and fiction. Are conspiracy theorists falsely claiming that a link between the Covid-19 vaccine and HIV infections? Verdict: TRUE The claim that the Covid-19 vaccine causes HIV infections is unfounded. According to an investigation on this misinformation is part of a conspiracy theory that has already been debunked by health experts and international health organisations. The Covid-19 vaccine does not contain HIV and has undergone rigorous safety tests before being distributed to the public. HIV is typically transmitted through sharing needles among drug users, unprotected sexual contact with an HIV-positive individual, or from mother to child during pregnancy. The misinformation spread widely on social media, where a post urged individuals allegedly infected with HIV by the vaccine to sue the Health Ministry. reports that this post received over 2,000 likes, 1,600 comments, and 1,000 shares. However, MyCheck also found several similar posts perpetuating the same falsehood. The confusion may stem from a misunderstanding of a vaccine study in Australia, which used a small fragment of the HIV protein as a molecular clamp to stabilise the SARS-CoV-2 spike protein. This vaccine was never approved or distributed to the public because it caused false positives in HIV tests, even though participants were not infected with HIV. Dr Mohd Rushdan Md Noor, a medical expert, explained, "The claim that the Covid-19 vaccine can spread HIV infection is false. "This misinformation is linked to the Covid-19 vaccine V451 developed by the University of Queensland and CSL in Australia. "The issue was that recipients of the V451 vaccine tested positive in HIV tests, but this was not due to HIV infection; it was a false positive result." Dr Rushdan further clarified the concept of false positives, stating, "Every test has false positives and false negatives. "If a healthy person tests positive, it's a false positive. If a sick person tests negative, it's a false negative. "There's no link between the Covid-19 V451 vaccine and HIV infection. "The vaccine was discontinued in 2020 to avoid confusion and public concern over the false positive results." also highlights that similar claims have been circulating since 2022, with the Indonesian Communication and Digital Ministry and Reuters Fact Check debunking the same misinformation. To reiterate, HIV infection can occur through sharing needles, unprotected sexual contact, and mother-to-child transmission, but not through Covid-19 vaccination. The notion that the Covid-19 vaccine causes HIV infection is entirely incorrect, as confirmed by scientific evidence and expert analysis. References: 1. php?id=2423512 2. check/australian-covid- vaccine-with-hiv-protein- misrepresented-online-2023-10- 05/ 3. images/media_sihat/kchs/KCHS_ 1992/pdf/BK_aids%20pembunuh. pdf 4. my/images/AIDSnov/aidsArtikel/ AIDS%20Dan%20Wanita%20(BM).pdf 5. vaksin-covid-19-menyebarkan- jangkitan-hiv-adalah-berita- palsusuntikan-v/ 10227390139567041/
